For organisations

Prevent sick leave whose MSD cause remains invisible.

Part of your MSD-related leave and occupational diseases has a neurological cause that standard examination does not see. Dynervolink provides a tailored clinical programme: screen exposed people, name the cause, and guide each one toward the right care, in support of your occupational health service.

Our value proposition

A complete journey, from screening to measuring results.

A modular programme, calibrated to your scope: a site, a department, a targeted role. Each step produces a deliverable usable on its own. Nothing replaces your obligations or the role of the occupational health service.

01 · Screen

Digital screening of employees

A scientifically validated dynamic questionnaire detects and prioritises at-risk situations within your organisation, for a global, ranked overview. Pseudonymised data, aggregated reporting to management, nothing identifying shared with the employer.

02 · Assess

In-depth clinical assessments

For people with a high score, a practitioner from the Institute conducts a structured dynervology assessment: symptoms, clinical tests, functional measurements, on site or at the institute. The nerve compression, if present, is named and its topography documented.

03 · Provide care

Care, self-management and workstation adaptation

Trained physiotherapists and ergonomists offer care, self-management techniques and simple workstation adaptations where relevant. The goal is maximum recovery and job retention. If progress remains insufficient, the person is guided toward our specialist physician.

04 · Measure

Retests and quality-of-working-life report

Retests measure progress. A final report ranks recommendations by feasibility and impact, directly usable within your prevention policy and your quality-of-working-life approach.

Four audiences, one discipline

Adapted to your organisation.

The dynervology reading adapts to exposed roles, to the specific framework of each organisation, and to the logic of care funders. The programme stays the same; its operational anchoring changes.

Private sector

Companies

Industry, logistics and services exposed to load handling, repetitive movements and prolonged postures. The programme connects with your quality-of-working-life agreement, your risk-assessment document (DUERP) and social dialogue, to reduce leave and unfitness in the most demanding roles.

Public sector

Public administrations

Nearly 2 million exposed agents across 1,400 target organisations (CNRACL, 2024). Screening and guidance of agents, from green spaces to early childhood, from school catering to administrative roles, together with prevention services and occupational health.

Clubs and federations

Elite sport

Dynamic nerve compressions linked to elite-level practice. A clinical reading integrated with the medical staff and reported to the sports physician, to spot the compression before it becomes a lasting unavailability.

Care funders

Health insurers & provident funds

Early clinical detection of under-diagnosed causes acts on MSD claims: shorter leave, fewer relapses, job retention. A medico-economic lever for health insurers, provident funds and prevention bodies.

The foundation of trust

Designed for occupational health, governing bodies and your DPO.

For an organisation, compliance is not an argument to be won, it is a prerequisite. It is set from the very design of the programme.

GDPR

Reporting to the individual alone

Clinical data is pseudonymised from collection (format DL-AAAA-XXXXX). No identifying data is shared with the employer or any third party. The individual assessment goes back to the employee or agent, who freely decides whether to share it with their physician.

Hosting

Strict EU sovereignty

All data is hosted within the European Union, with an operator not subject to the US CLOUD Act. No transfer outside the EU, neither direct nor indirect via third-party providers.

Regulatory status

A triage tool, not a medical device

The digital tools are qualified as triage and guidance aids, under the responsibility of AFD-referenced practitioners. No medical-device claim is made before the EU MDR 2017/745 qualification targeted for 2030.

Articulation

In support, never as a substitute

The programme fits within your prevention plan (DUERP, annual programme) and your quality-of-working-life policy. It adds no burden to your teams and replaces none of your regulatory obligations or the role of occupational health.

Connected to your framework

Articulated with your prevention and health ecosystem.

Dynervolink replaces no actor in your system. The programme fits within the existing framework and connects with prevention and health institutions.

Occupational health

In support, never as a substitute

Clinical screening equips occupational health with an additional reading, reported to the employee or agent, without substituting for its role.

CARSAT

Prevention of occupational risks

The programme connects with occupational-risk prevention initiatives and with sector schemes such as TMS Pro.

Assurance Maladie · CPAM

Claims and funding

By acting on under-diagnosed causes, the programme targets MSD claims; several prevention funding schemes can be mobilised depending on eligibility.

ARS

Territorial coherence

Deployment is consistent with regional public-health priorities, a support for public actors and local authorities.

Frequently asked questions

What organisations ask us.

What is dynervology?

A clinical discipline structured around dynamic nerve compressions, a neurological component of MSDs that is often under-detected by standard examination. It is led by an independent academy (AFD) and operated at the Institut de Dynervologie de Tours Métropole.

How is it different from a quality-of-working-life programme or an MSD prevention app?

It is not a self-exercise app. Dynervolink adds the clinical screening of a hidden nerve cause and guides each exposed person toward the right care, in connection with your occupational health service.

How does the programme fit with our occupational health service?

In support of occupational health and your prevention policy, with no additional organisational burden. The approach fits within the French regulatory framework and the guidance of the relevant authorities (ARS, HAS).

What return can be expected?

Avoiding a single long absence or relapse is usually enough to make a structured screening and guidance programme worthwhile. The costs of MSDs are documented by official sources (INRS, Assurance Maladie, CNRACL).

How is the data protected?

Pseudonymised data, sovereign hosting within the European Union, and no identifying data shared with the employer. GDPR compliance is strict.

Is it a medical device? Do you make a diagnosis?

No. As of today, the Dynervolink tools are triage and guidance aids, with no medical or diagnostic claim, operated upstream of the care pathway under the responsibility of AFD-referenced practitioners. Qualification as a digital medical device is a horizon targeted for 2030.

Which sectors does Dynervolink address?

Companies, public administrations and professional sport, always in support of occupational health.

How do we get started?

Through a no-commitment scoping conversation to gauge your exposure and the programme suited to your organisation.

Going further

Request a scoping call.

HR director, quality-of-working-life lead, head of prevention or occupational health: the team sends a detailed brief (typical scope, terms and contractual references) and frames the first step with you.